profmakris.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

Recombinant ADAMTS13 should be the standard of care for patients with congenital TTP. FFP is an inferior product both in terms of efficacy and safety. A paper in the journal Blood describes the experience from Japan in 14 patients. lnkd.in/eXg345SD

submitted 24 days ago • 0 comments

For anybody interested in birds, this is a great book. The author tried to learn more about birds by building a shed/hide close to his home in the south of England. Very well researched and informative. I learnt a lot about the birds we encounter in the UK.

submitted 26 days ago • 0 comments

If you are interested in birds, the Greek island of Lesbos is a great place to visit this time of the year, as it coincides with the spring migration. We saw 170 species of bird in one week thanks to the skills of "Mr Lesbos Birding" Howard Vaughan, who also took the bird pictures below.

submitted 32 days ago • 0 comments

My commentary on PITT (PF4-associated immune thrombocytopenia and thrombosis) has just been published in the British Journal of Haematology. This group of disorders is more than HIT and VITT and we should be looking for it more widely. onlinelibrary.wiley.com/doi/10.1111/...

submitted 35 days ago • 0 comments

Our editorial on the Paradox of Choice in Hemophilia has just been published in the journal Research and Practice in Thrombosis and Haemostasis. Like all papers in this journal, it is freely available. tinyurl.com/4kw9hcth @rpth.bsky.social #hemophilia #haemophilia

submitted 49 days ago • 0 comments

Thank you. In addition, there were no cases of malignancy following gene therapy, but the number of patients and years of follow-up is small.

submitted 51 days ago • 0 comments

A paper in @NEJM describes 14 patients with #hemophilia B who had the Pfizer gene therapy. Their achieved FIX levels remained stable over a median of 5.5 years. Confirmation that durability following hemophilia B gene therapy is very different to that in hemophilia A. tinyurl.com/2b2zzc37

submitted 52 days ago • 0 comments

An article in the current issue of @nejm.org discusses the impact of the US foreign assistance cuts on global health. Some of the impacts are not readily obvious. The authors advocate reforming the foreign assistance program rather than dismantling it.

submitted 52 days ago • 0 comments

The BIC meeting in Italy is always a great meeting, showcasing the latest science and with plenty of time for discussion. Remember the deadline for abstract submission is the 30th April 2025. #hemophilia #VWD #TMA #TTP

submitted 52 days ago • 0 comments

Today is #WorldHemophiliaDay and this year's theme is that women and girls bleed too. Despite the development of brilliant treatments to treat severe #hemophilia primarily in men, the diagnosis and treatment of women have not received as much attention.

submitted 53 days ago • 0 comments

This is the press release about the new #hemophilia B gene therapy that has been approved in China. So there are now 3 approved gene therapies for hemophilia B, 2 in US/Europe approved by the FDA/EMA and 1 in China approved by the Chinese regulator. tinyurl.com/2jc74nb9

submitted 59 days ago • 0 comments

Thank you for the copies of the paper on the UK Infected Blood Inquiry that was published in @BloodJournal. It is interesting to see the section on lessons learned. Despite the @bloodinquiry, the UK continues to use cryo and FFP without viral inactivation. #hemophilia

submitted 59 days ago • 0 comments

Article on Generative AI in medicine published today in @nejm.org. It discusses the potential uses and risks. One issue you can be sure of, is that AI will be embedded in the everyday practice of medicine in the very near future, even more than today. tinyurl.com/4sbjpjvs

submitted 59 days ago • 0 comments

Join Cedric Hermans and @profmakris.bsky.social in this E-learning Insight session as they share practical strategies and key considerations to help you navigate the world of scientific publishing. Learn how to write with purpose and make your research stand out.📺 academy.eahad.org/eahad/2023/e...

submitted 60 days ago • 0 comments

If you are a scientist who is not using AI yet, this article from today's @nature.com journal will be of great help. Whether we like it or not, AI will be everywhere very soon, just like the internet.

submitted 61 days ago • 0 comments

Everybody has an opinion about racism, but as the author of this book explains, the plural of anecdote is not data. This is a serious book looking at the scientific evidence around racism. It will not come as a surprise to read that racism is still in everything.

submitted 64 days ago • 0 comments

Pseudoscience. #MedSky

submitted 65 days ago • 1 comment

Vaccination skeptics should have a look at this figure. It shows the impact of the introduction of RSV vaccination for patients aged 75-80 on hospital admissions in the UK. tinyurl.com/5d48u7mm

submitted 65 days ago • 0 comments

Important paper: In patients with cancer and venous thrombosis, extended anticoagulation with low dose Apixaban is as good as full dose Apixaban in preventing thrombosis recurrence and is associated with less bleeding. tinyurl.com/yyfuan35

submitted 66 days ago • 0 comments

Professor Christine Lee reflects on some of the conclusions of the UK Infected Blood Inquiry. The manuscript has just been published by the journal Haemophilia. @haemophilia_jnl #hemophilia. The PDF of the manuscript is freely available at: tinyurl.com/mvh2mk22

submitted 66 days ago • 0 comments

Our paper on the severity of #hemophilia has just been published in the journal Hemasphere. Baseline clotting factors do not always accurately reflect the severity of the disease. tinyurl.com/3hn9hhrn

submitted 66 days ago • 0 comments

Our paper on inhibitor trends is now published in the journal Haemophilia. The number of inhibitors in previously untreated patients has markedly reduced, but it is possible that this is due to delayed exposure to FVIII. tinyurl.com/2mr3t5e3

submitted 66 days ago • 0 comments

The German authorities have today concluded their negotiations with CSL Behring and agreed the price they will pay for the #hemophilia B gene therapy (Hemgenix). Does anybody know how much they will pay? tinyurl.com/mpnc9kk7

submitted 66 days ago • 0 comments

Comprehensive review of gene therapy in #hemophilia accepted for publication by Molecular Therapy. The pre-proof is on line at tinyurl.com/3sb4nuex

submitted 69 days ago • 0 comments

Paying reviewers to assess papers submitted to scientific journals results in more rapid reviews, but the quality does not change. News article in @nature.com. tinyurl.com/bdfxf9xy

submitted 69 days ago • 0 comments

Incredible: dropbox.com/scl/fi/qy2ja.... This podcast was produced 100% by AI. It is entirely based on the editorial by myself and Brian O'Mahony published in @rpth.bsky.social. It is 21 min and remarkably accurate. Thank you, Eugene Fan, for showing me what is possible.

submitted 70 days ago • 0 comments

This is an amazingly prophetic book written by two Harvard professors who teach political science. Although published in 2018, it clearly describes what is happening in the world and the US in particular today. "History does not repeat itself; it rhymes."

submitted 71 days ago • 0 comments

Do you want the latest updates in #platelet research? 🔥 Check out these Illustrated Capsules from the Advanced Course in Platelet Research held in Spain in September 2024. Supported by @isth.org and the SETH www.rpthjournal.org/article/S247...

submitted 73 days ago • 0 comments

As expected the FDA has today announced that it has approved Fitusiran for individuals aged 12+ with #hemophilia A or B with or without inhibitors. Commercial name is Qfitlia - they must have tried hard to find a difficult to pronounce name. tinyurl.com/mr4xmawt

submitted 72 days ago • 0 comments

Tomorrow, March 28th, is the big day for Fitusiran as the FDA is expected to give their decision. Will they approve it? Probably. Will it have a black box warning? We do not know, but since they did not use them for Marstacimab and Concizumab, they will probably not. #hemophilia

submitted 73 days ago • 0 comments

If you are still unsure whether to ask for your data to be deleted by 23andMe and any retained samples destroyed, have a read of this article in the New England Journal of Medicine @nejm.org.

submitted 73 days ago • 0 comments

Our editorial on #hemophilia treatments and the paradox of choice is now available in the journal Research and Practice in Thrombosis and Haemostasis. www.rpthjournal.org/article/S247...

submitted 74 days ago • 0 comments

Von Willebrand disease associated angiodysplasia can be challenging to manage. I suspect the best treatment will be targeting angiogenesis rather than VWD. Excellent review on the subject in Haematologica. tinyurl.com/vu7n9w5h

submitted 74 days ago • 0 comments

If you have used 23andme.com for analysis of your genome like me, you may wish to read this document from the California Attorney General about requesting deletion of your data and destruction of your sample before the company is taken over. oag.ca.gov/news/press-r...

submitted 76 days ago • 0 comments

I bought this book when META/Facebook (who claim to believe in free speech) got a Gag order to stop the author promoting the book! The author was a senior employee at Facebook, and this is her memoir. What she writes about Facebook will shock all readers because the results impact everybody.

submitted 77 days ago • 0 comments

I am running for Clinical VP of the RCP. For those who don't know me, here is a potted bio. 🧵

submitted 84 days ago • 1 comment

Access to affordable rivaroxaban 2.5mg tablets could be a game changer for patients with PAD. This drug, when combined with low-dose aspirin, prevents MI, stroke, and limb amputations!

submitted 87 days ago • 0 comments

The generic versions of the Direct Oral Anticoagulants (DOACs) are coming. First FDA approval for generic Rivaroxaban (Xarelto) 2.5mg tablets. The real need is for the 10, 15, and 20 mg tablets; let's hope the delay is not too long. Also for the other DOACs. tinyurl.com/ypmmmnmf

submitted 87 days ago • 0 comments

The new dosing method for Fitusiran appears to provide equal efficacy without thrombotic events. The number of patients, however, is very small. Safety will only be demonstrated with real world data on a much larger number of patients. tinyurl.com/mupbhanr

submitted 88 days ago • 0 comments

Public opinion of Putin and Trump I'm Spain, France, UK and Italy. For some peculiar reason the graphs look better on their side.

submitted 94 days ago • 32 comments

"The defeat of #Ukraine would be the defeat of Europe. The Baltic States, Georgia and Moldova are already on the list. Putin’s goal is to return to Yalta, where half the continent was ceded to Stalin." - French Senator Claude Malhuret made an excellent speech.

submitted 94 days ago • 52 comments

French Senator Claude Malhuret: "Washington has become Nero’s court, with an incendiary emperor, submissive courtiers and a jester high on ketamine... We were at war with a dictator, we are now at war with a dictator backed by a traitor."

submitted 95 days ago • 1733 comments

Obituary of an Australian blood donor. Despite having only one lung, he donated 1173 times between 1954 and 2018 and contributed to every batch of anti-D made in Australia. Amazingly, in Australia, the maximum age for blood donation is 81 years. tinyurl.com/yme2hck8

submitted 96 days ago • 0 comments

Editorial in the @NEJM about the current assault on science in the US. "As editors, we should continue to do what we think makes a difference.

submitted 97 days ago • 0 comments

Does anybody know how independent the European site (europepmc.org) is from PubMed? Can EuropePMC go it alone without any links to PubMed? 2/2 #PubMed

submitted 99 days ago • 4 comments